Launching the Sino-Korean Clinical Research Center System

In-depth Research on Sino-Korean Medical Technology x Product R&D Source

Second Stop: Beijing & Fujian Region

On June 20, 2024, DCELL / D+JU PN continues to promote the Sino-Korean Clinical Research Center system. The second stop of this source visit to Korea group will be in the Beijing and Fujian regions. This event sincerely invites Chinese experts from Dcell to engage in academic exchanges in Korea, focusing on the analysis of PN & PDRN and practical teaching of the dual Di combined therapy.

Innovating the Medical Aesthetics Landscape with an International Perspective

In recent years, the development of the medical aesthetics field in both China and Korea has garnered significant attention, each with its unique characteristics and development paths. The potential and consumption power of the Chinese medical aesthetics market cannot be underestimated, with increasing demand from beauty seekers for aesthetic enhancements. Korea boasts advanced medical aesthetics technology and facilities, driven in part by a robust R&D center system. Both sides are continuously strengthening technical exchanges and cross-border cooperation, enhancing overall medical technology levels and service quality.

As a pioneer in the field of skin research and repair, DCELL / D+JU PN stands at the forefront of technology and market, constantly exploring possibilities for innovation and development. We focus on product R&D sourcing, the differentiated demands of the Sino-Korean skin beauty market, and in-depth research on the project integration and packaging experience of Korean institutions, bringing academic and authoritative insights to the industry.

Evidence-Based Science and Innovative Research: Product R&D Center Visit

From technological innovation to market promotion, Korean pharmaceutical groups are continuously driving product iteration and optimization by establishing R&D centers. These centers serve not only as bastions of scientific research but also as key hubs for transforming theory into practical products.

During our visit, we toured the cutting-edge technology facilities of the Korean PR R&D Center, which has a large number of professional R&D personnel and rich academic resources. They are dedicated to innovative technology, developing efficient and safe aesthetic products that meet market demands. Every step, from ingredient extraction and technology R&D to clinical testing, strictly adheres to scientific standards.

The core ingredients of DCELL / D+JU PN products are extracted using DOT specialized technology. The R&D factory meets EU-GMP international safety standards and is equipped with automated engineering devices. The entire production line follows multiple sterile processes, including pH treatment and high-temperature high-pressure steam sterilization, certified by third-party monitoring agencies, ensuring a strictly regulated and standardized preparation process.

Through joint research and technology sharing, we continuously enhance the technical content and market competitiveness of our products. This model of combining production, academia, and research significantly improves the scientific and effective nature of the products.

Differentiated Integration and Project Customization: MAYLIN CLINIC Exchange

Exploring the differentiated demands and integration adjustments of the Sino-Korean medical aesthetics market

During this residency exchange, we discovered significant demand differences between the skin beauty markets of China and Korea. This is reflected not only in the preferences of beauty seekers but also in the directions of technology and product innovation. Korean beauty seekers' pursuit of high-tech and efficient results drives continuous improvements in product performance, while the Chinese market places greater emphasis on personalized needs and long-term effects.

Behind this demand difference lies the distinct perceptions and cultural backgrounds of beauty seekers in both countries regarding skin aesthetics. Korea emphasizes "seeing the big picture through small details," aiming for overall beauty through detailed improvements; whereas China pursues "comprehensive enhancement," seeking multifunctional products for holistic care. Dcell is strategically adjusting and upgrading its product efficacy positioning and market strategies to meet the specific beauty needs of different markets.

Korean Institutional Project Packaging Experience Sharing

Korean institutions have accumulated rich experience in project integration and packaging. Through systematic project design and refined packaging solutions, they have enhanced market acceptance and customer satisfaction. They focus on the overall nature of projects, organically combining skin care, anti-aging, and whitening into a one-stop beauty solution. This integrated project design not only improves customer experience but also enhances the added value of the projects.

Furthermore, Korean institutions emphasize personalization and customization in project packaging. Through detailed skin assessments and analyses, they tailor the most suitable medical aesthetics plans for each beauty seeker. This personalized service model not only enhances customer trust and loyalty but also drives word-of-mouth promotion for the projects.

Practical Discussion and Authoritative Certification

Both China and Korea possess rich practical experience and R&D achievements in medical aesthetics technology. As a pioneer in medical aesthetics technology, Korea has long led global market trends with its technological accumulation. Its strict technical standards and clinical practice experiences set benchmarks for the industry. During the event, Director Park Hyun-jun from MAYLIN CLINIC conducted practical demonstrations of the products, facilitating learning and exchanges on the dual Di combined therapy, aiding in the enhancement of physician skills.

Through practical training and certification, physicians will systematically master the latest techniques and treatment methods, ensuring the safety and controllability of operations. The Sino-Korean practical discussions in medical aesthetics not only serve as a platform for technical exchanges but also as an important mechanism for promoting industry development and enhancing practitioners' capabilities.

Insightful Excellence and Collaborative Progress

DCELL / D+JU PN will always adhere to the principles of innovation and excellence, continuously exploring the differentiated demands of the Sino-Korean medical aesthetics market. Through precise project integration and packaging strategies, we aim to provide beauty seekers with a higher quality medical aesthetics experience. In the future, we will continue to promote cross-border clinical research cooperation, advancing the progress of medical aesthetics technology and injecting new energy and vitality into industry development.